Disease-modifying  	Disease-modifying  	 JJ	O
anti-rheumatic  	anti-rheumatic  	 JJ	B-NP
drugs  	drugs  	 NNS	I-NP
in  	in  	 IN	O
rheumatoid  	rheumatoid  	 JJ	B-NP
arthritis  	arthritis  	 NN	I-NP
and  	and  	 CC	O
ankylosing  	ankylosing  	 FW	B-NP
spondylitis  	spondylitis  	 FW	I-NP
Disease  	Disease  	 FW	I-NP
modifying  	modifying  	 FW	I-NP
antirheumatic  	antirheumatic  	 FW	I-NP
drugs  	drugs  	 FW	I-NP
( 	( 	 -LRB-	O
DMARDs 	DMARDs 	 NNP	B-NP
)  	)  	 -RRB-	O
are  	are  	 VBP	O
widely  	widely  	 RB	O
used  	used  	 VBN	O
and  	and  	 CC	O
well  	well  	 RB	O
accepted  	accepted  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
rheumatoid  	rheumatoid  	 JJ	B-NP
arthritis  	arthritis  	 NN	I-NP
( 	( 	 -LRB-	O
RA 	RA 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Many  	Many  	 JJ	O
studies  	studies  	 NNS	O
have  	have  	 VBP	O
been  	been  	 VBN	O
performed  	performed  	 VBN	O
with  	with  	 IN	O
monotherapy  	monotherapy  	 NN	B-NP
and  	and  	 CC	O
combinations  	combinations  	 NNS	B-NP
of  	of  	 IN	O
DMARDs  	DMARDs  	 JJ	O
showing  	showing  	 VBG	O
their  	their  	 PRP$	O
efficacy  	efficacy  	 NN	O
and  	and  	 CC	O
safety 	safety 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
ankylosing  	ankylosing  	 JJ	B-NP
spondylitis  	spondylitis  	 NNS	I-NP
( 	( 	 -LRB-	O
AS 	AS 	 NNP	B-NP
)  	)  	 -RRB-	O
DMARDs 	DMARDs 	 NNP	B-NP
,  	,  	 ,	O
sulfasalazine  	sulfasalazine  	 VBD	O
especially 	especially 	 RB	O
,  	,  	 ,	O
are  	are  	 VBP	O
recommended  	recommended  	 VBN	O
only  	only  	 RB	O
for  	for  	 IN	O
the  	the  	 DT	O
peripheral  	peripheral  	 JJ	B-NP
involvement  	involvement  	 NN	I-NP
and  	and  	 CC	O
not  	not  	 RB	O
for  	for  	 IN	O
the  	the  	 DT	O
axial  	axial  	 JJ	B-NP
symptoms 	symptoms 	 NNS	I-NP
.  	.  	 .	O
For  	For  	 IN	O
this  	this  	 DT	O
disease  	disease  	 NN	O
there  	there  	 EX	O
is  	is  	 VBZ	O
a  	a  	 DT	O
lack  	lack  	 NN	O
of  	of  	 IN	O
clinical  	clinical  	 JJ	B-NP
trials  	trials  	 NNS	I-NP
and  	and  	 CC	O
most  	most  	 JJS	O
of  	of  	 IN	O
the  	the  	 DT	O
trials  	trials  	 NNS	O
did  	did  	 VBD	O
not  	not  	 RB	O
show  	show  	 VB	O
efficacy  	efficacy  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
axial  	axial  	 JJ	B-NP
symptoms  	symptoms  	 NNS	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
disease 	disease 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
paper 	paper 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
differences  	differences  	 NNS	O
and  	and  	 CC	O
similarities  	similarities  	 NNS	B-NP
of  	of  	 IN	O
DMARDs  	DMARDs  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
RA  	RA  	 NNP	B-NP
and  	and  	 CC	O
AS  	AS  	 NNP	O
patients  	patients  	 NNS	O
will  	will  	 MD	O
be  	be  	 VB	O
discussed 	discussed 	 VBN	O
.  	.  	 .	O
